Lenvima (lenvatinib)

pCPA File Number: 21091
Negotiation Status:
Negotiations were not pursued
Indication(s):
Advanced or Metastatic Clear-cell Renal Cell Carcinoma
Sponsor/Manufacturer:
Eisai Limited
CDA-AMC Project Number:
PC0140-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: